FORM 10-K

Company

Edesa Biotech, Inc.

Filed

December 13, 2024

Period of Report

September 30, 2024

Accession Number

0001171843-24-006946

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →